You have 9 free searches left this month | for more free features.

Nontuberculous Mycobacterial Pulmonary Infection

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transmission and Acquisition of Nontuberculous Mycobacteria

Recruiting
  • Nontuberculous Mycobacterial Pulmonary Infection
  • +3 more
  • Epidemiologic investigation
  • Denver, Colorado
    National Jewish Health
Dec 1, 2023

Prospective Healthcare-Associated Links in Transmission of

Enrolling by invitation
  • Cystic Fibrosis
  • Nontuberculous Mycobacterial Pulmonary Infection
    • Denver, Colorado
      National Jewish Health
    Jan 6, 2023

    PK and PD of Antibiotics for Treatment of Mycobacterium

    Not yet recruiting
    • Nontuberculous Mycobacterial Pulmonary Infection
    • Measuring PK and PD indices in patients who receive conventional treatment
    • (no location specified)
    Dec 22, 2022

    Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

    Not yet recruiting
    • Mycobacterium Avium Complex Pulmonary Disease
    • (no location specified)
    May 15, 2023

    Mycobacterium Abscessus Infection in Chronic Lung Disease and

    Enrolling by invitation
    • Mycobacterium Abscessus Infection
    • +2 more
    • Appropriate treatment
    • Pathum Wan, Bangkok, Thailand
      King Chulalongkorn Memorial Hospital
    Aug 31, 2022

    Expectorated and Induced Sputum and Pharyngeal Swabs for

    Completed
    • Myobacterium Infections, Nontuberculous
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

      Recruiting
      • Mycobacterium Infections, Nontuberculous
      • +3 more
      • Omadacycline Oral Tablet
      • Placebo
      • Birmingham, Alabama
      • +20 more
      Jan 11, 2023

      Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

      Recruiting
      • Nontuberculous Mycobacterial Lung Disease
      • Nontuberculous Mycobacterium Infection
      • Hypertonic saline
      • +3 more
      • New York, New York
      • +2 more
      Jan 27, 2023

      Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

      Terminated
      • Mycobacterium Infections, Nontuberculous
      • Cystic Fibrosis (CF)
      • Molgramostim nebulizer solution
      • PARI eFlow nebulizer system
      • Denver, Colorado
      • +4 more
      Oct 10, 2021

      Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

      Not yet recruiting
      • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
      • Placebo
      • +2 more
      • (no location specified)
      Aug 9, 2022

      Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)

      Completed
      • Nontuberculous Mycobacterium Infection
      • Portland, Oregon
      • +1 more
      May 17, 2021

      Nontuberculous Mycobacterial Lung Disease Trial in Shanghai (New regimen(BdqCfzLzd+XY))

      Not yet recruiting
      • Nontuberculous Mycobacterial Lung Disease
      • New regimen(BdqCfzLzd+XY)
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Aug 8, 2022

      Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)

      Not yet recruiting
      • Nontuberculous Mycobacterium Infection
      • Mycobacterium Abscessus Infection
      • (no location specified)
      Aug 21, 2023

      Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

      Active, not recruiting
      • Mycobacterium Infections, Nontuberculous
      • Birmingham, Alabama
      • +110 more
      Jan 23, 2023

      Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

      Completed
      • Mycobacterium Infections, Nontuberculous
      • Inhaled molgramostim
      • Concord, New South Wales, Australia
      • +4 more
      Mar 23, 2021

      Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)

      Completed
      • Cystic Fibrosis
      • Aurora, Colorado
        Children's Hospital Colroado
      Jan 20, 2021

      Study of Mycobacterial Infections

      Recruiting
      • Mycobacterium Infections
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,

      Recruiting
      • Mycobacterium Avium Complex
      • Nontuberculous Mycobacterium Infection
      • Loma Linda, California
      • +26 more
      Jan 18, 2023

      Clarith/Klaricid in Non-tuberculous Mycobacterial Pulmonary

      Completed
      • Mycobacterium Infections, Atypical
        • Aichi, Japan
        • +58 more
        Mar 18, 2022

        Drug Exposure and Minimum Inhibitory Concentration in Treatment

        Not yet recruiting
        • Mycobacterium Avium Complex
        • +3 more
        • Drug exposure
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Apr 10, 2023

        Mycobacterial and Opportunistic Infections in HIV-Negative Thai

        Active, not recruiting
        • Non-Tuberculous Mycobacteria
        • +2 more
          • Taiwan, China
            National Taiwan University
          Aug 18, 2022

          Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

          Recruiting
          • Non-Tuberculous Mycobacterial Pneumonia
          • +4 more
          • LungFit
          • Greenslopes, Queensland, Australia
            Gallipoli Medical Research Foundation
          Dec 24, 2020

          Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul

          Not yet recruiting
          • Mycobacterium Avium Complex Pulmonary Disease
            • Seoul, Korea, Republic of
              Seoul National University Hospital
            Jun 7, 2023

            Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

            Completed
            • Mycobacterium Infections, Nontuberculous
            • LAI (Liposomal Amikacin for Inhalation) 590 mg
            • (no location specified)
            Apr 22, 2020

            Multiplex PCR -Microarray-based Assay in Detection of

            Completed
            • Tuberculosis
            • Non-Tuberculous Mycobacterial Pneumonia
            • VereMTB
            • Sha Tin, Hong Kong
              Prince of Wales Hospital
            Aug 7, 2022